Clinical Trial Update: Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

This is a completed Phase 2 trial evaluating the DOS regimen (docetaxel, oxaliplatin, and S-1) for advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Stomach Neoplasms | Phase 2 | Status: COMPLETED